WP
VERA icon

Woodline Partners’s Vera Therapeutics VERA Stock Holding History

Woodline Partners’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43M Hold
1,001,037
– – 0.13% 203
2026
Q1 		$40.3M Buy
1,001,037
+758
+0.1% +$32.7K 0.15% 173
2025
Q4 		$50.7M Buy
1,000,279
+262,701
+36% +$9.33M 0.2% 124
2025
Q3 		$21.4M Sell
737,578
-1,870,794
-72% -$43.3M 0.1% 269
2025
Q2 		$61.5M Buy
2,608,372
+1,607,523
+161% +$36.1M 0.32% 71
2025
Q1 		$24M Sell
1,000,849
-201,617
-17% -$6.48M 0.16% 191
2024
Q4 		$50.9M Buy
1,202,466
+201,573
+20% +$8.92M 0.34% 79
2024
Q3 		$44.2M Buy
1,000,893
+51,976
+5% +$1.97M 0.37% 79
2024
Q2 		$34.3M Buy
948,917
+1,820
+0.2% +$72.2K 0.33% 86
2024
Q1 		$40.8M Sell
947,097
-1,560,043
-62% -$55.6M 0.38% 78
2023
Q4 		$38.6M Sell
2,507,140
-55,460
-2% -$704K 0.42% 67
2023
Q3 		$35.1M Buy
2,562,600
+808,910
+46% +$13.9M 0.41% 56
2023
Q2 		$28.1M Buy
1,753,690
+972
+0.1% +$8.78K 0.33% 90
2023
Q1 		$13.6M Buy
1,752,718
+1,603,165
+1,072% +$12.4M 0.19% 158
2022
Q4 		$2.89M Sell
149,553
-19,724
-12% -$357K 0.04% 421
2022
Q3 		$3.61M Buy
+169,277
New +$3.17M 0.05% 354

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Woodline Partners's VERA Position: Q2 2026 in Review

Woodline Partners held its Vera Therapeutics (VERA) position steady in Q2 2026 at 1,001,037 shares worth $43M. The position accounts for 0.13% of the portfolio, ranked #203.

Woodline Partners first reported a position in VERA in Q3 2022 and has held it in 16 quarters since. The position peaked at $61.5M in Q2 2025. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Woodline Partners held 1,001,037 shares of Vera Therapeutics worth $43M as of Q2 2026.
  • Woodline Partners left its Vera Therapeutics share count unchanged in Q2 2026.
  • Vera Therapeutics made up 0.13% of Woodline Partners's portfolio in Q2 2026, its #203 holding.
  • Woodline Partners first reported a position in Vera Therapeutics in Q3 2022 and has held it in 16 quarters since.
  • Woodline Partners's Vera Therapeutics position peaked at $61.5M in Q2 2025.
  • 220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.